PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1371992
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1371992
Brain and Neuroimaging Devices Market Forecasts to 2030 - Global Analysis By Imaging Type, Procedure, Application, End User and By Geography
According to Stratistics MRC, the Global Brain and Neuroimaging Devices Market is accounted for $22.4 billion in 2023 and is expected to reach $36.2 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Brain and neuroimaging devices are medical devices used to capture the structure, function, or pharmacology of the brain and locate areas affected by neurological disorders. The area of medical imaging known as neuroimaging focuses on the brain. Neuroimaging investigates how the brain functions in addition to identifying diseases and evaluating brain health. Neuroscientists can view the interior of the living brain using brain imaging devices.
According to the National Institute of Health, funding for neurodegenerative diseases was US$ 4,021 million in 2020.
Market Dynamics:
Driver:
Technology advancements
Technology advancements have increased the functionality and effectiveness of brain and neuroimaging device. The ability to investigate brain anatomy and function, for instance, has improved with the introduction of high-resolution imaging techniques like functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI). Additionally, as a result of technological advancements, the market is still growing since they make it possible for scans to be completed more quickly and with more patient comfort.
Restraint:
High cost of imaging equipment
The market for brain and neuroimaging technologies is predicted to suffer from the high cost of imaging equipment. High-end equipment is needed for brain-computer interface research in cognitive psychology and neurology, including functional magnetic resonance imaging (fMRI), positron emission tomography (PET), and electroencephalography (EEG). However, these are expensive devices that not all hospitals and laboratories, particularly in developing nations, can afford. Therefore, the high cost of imaging systems, which limits the purchasing power of hospitals and diagnostic labs, is a barrier to the market for brain and neuroimaging devices.
Opportunity:
Personalized medicine and precision imaging
The objective of personalised medicine is to modify medical care in accordance with a patient's particular traits, including their particular brain structure and function. Neuroimaging technology can be quite useful in delivering individualised information for better treatment planning and neurological condition monitoring. Furthermore, in order to find patient-specific biomarkers and improve treatment outcomes, precision imaging approaches, including functional connectivity mapping and multimodal imaging integration, are being developed, which expands the market.
Threat:
Regulatory challenges
The market for brain and neuroimaging devices is subject to strict rules and authorization from regulatory agencies, including the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). Additionally, it might take time and money to obtain regulatory clearance or approval for new imaging technologies or devices. Companies in this area face difficulties adhering to evolving regulatory norms and criteria. These regulatory challenges hinder market growth.
COVID-19 Impact
The COVID-19 epidemic has had a wide range of effects on the market and the field of neuroimaging devices. The use of neuroimaging tools like MRI and CT scans in clinical settings increased as medical practitioners sought to comprehend exactly the virus affected the brain and the associated neurological symptoms. The demand for these gadgets and associated technologies increased as a result. The epidemic delayed the production and distribution of medical equipment, especially neuroimaging devices, and interrupted supply networks.
The ambulatory surgical centers segment is expected to be the largest during the forecast period
The ambulatory surgical centers segment is estimated to hold the largest share. In the market for brain and neuroimaging devices, the Ambulatory Surgical Centres (ASCs) segment is particularly important for the diagnosis and management of neurological diseases. These facilities frequently act as outpatient settings for a variety of medical interventions, such as neurosurgery and interventional radiological procedures, where neuroimaging technologies are crucial instruments. Neuroimaging equipment will continue to be crucial to the diagnostic and therapeutic pathways within ASCs as healthcare systems prioritise outpatient care and minimally invasive procedures.
The cerebral oximeters segment is expected to have the highest CAGR during the forecast period
The cerebral oximeters segment is anticipated to have lucrative growth during the forecast period. The Cerebral Oximeters, which specialises in measuring and evaluating cerebral oxygenation levels, is an essential part of the brain and neuroimaging devices industry. These tools, including near-infrared spectroscopy (NIRS) systems, are essential for non-invasively detecting the oxygen saturation levels in the brain's tissues and delivering significant information for evaluating cerebral health. In a variety of medical settings, such as operating rooms, neonatal care units, and research labs, these devices are increasingly used because they provide insightful information on brain health.
Region with largest share:
Asia Pacific commanded the largest market share during the extrapolated period due to advanced healthcare infrastructure, substantial R&D investments, and a high prevalence of neurological disorders. With a vast network of hospitals, clinics, and research facilities, North America has one of the most sophisticated healthcare infrastructures in the world. This infrastructure makes it easier to acquire and use neuroimaging technology for both research and clinical diagnosis. Numerous neurological injuries, multiple sclerosis, Alzheimer's disease, Parkinson's disease, and other conditions are relatively common in this region.
Region with highest CAGR:
Europe is expected to witness profitable growth over the projection period. Europe is characterised by a strong healthcare system, cutting-edge medical technology, and a rising interest in neurological illnesses. A network of contemporary hospitals, clinics, and research facilities is part of Europe's established and extensive healthcare infrastructure. This infrastructure encourages the adoption and use of neuroimaging technology for clinical diagnosis and academic study. For early diagnosis, disease monitoring, and research, this high disease prevalence increases the need for improved neuroimaging technologies. Neuroimaging methods are more widely available to patients and medical professionals in many European nations thanks to favourable payment regulations.
Key players in the market:
Some of the key players in the Brain and Neuroimaging Devices Market include: Canon, Hitachi Medical Systems, General Electric Company, Philips, Varian Medical Systems, Siemens, Toshiba Medical Systems, NeuroSoft, Sanrad Medical Systems Pvt. Ltd, Esaote SpA, Medtronic Plc, Elekta AB, Natus Medical Incorporated, Magstim Company Ltd., Compumedics Limited and Brainlab AG.
Key Developments:
In August 2022, Siemens Smart Infrastructure (SI), the market leader in digital buildings, completed the acquisition of Brightly Software, a leading asset and maintenance management software-as-a-service (SaaS) provider based in the United States. The acquisition propels SI to the forefront of the software market for buildings and built infrastructure.
In April 2022, Varian, a Siemens Healthineers company, announced a five-year research and professional services agreement with Icon Group (Icon). Icon may participate in clinical and technical research programs, product evaluation projects, and consultations with Varian under this agreement to provide clinical expertise and industry perspectives throughout product development.
Imaging Types Covered:
- Computed Tomography
- Functional Magnetic Resonance Imaging
- Positron Emission Tomography
- Electroencephalography
- Near Infrared Spectroscopy
- Magneto encephalography
- Intracranial Pressure Monitors
- Cerebral Oximeters
- Sleep Monitoring Devices
- Electromyography Devices
- Other Imaging Types
Procedures Covered:
- Invasive
- Non-Invasive
Applications Covered:
- Traumatic Brain Injury
- Dementia
- Parkinson's Disease
- Sleep Disorders
- Epilepsy
- Huntington's Disease
- Headache Disorders
- Other Applications
End Users Covered:
- Ambulatory Surgical Centers
- Diagnostic Centers
- Hospitals
- Clinics
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Application Analysis
- 3.7 End User Analysis
- 3.8 Emerging Markets
- 3.9 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Brain and Neuroimaging Devices Market, By Imaging Type
- 5.1 Introduction
- 5.2 Computed Tomography
- 5.3 Functional Magnetic Resonance Imaging
- 5.4 Positron Emission Tomography
- 5.5 Electroencephalography
- 5.6 Near Infrared Spectroscopy
- 5.7 Magnetoencephalography
- 5.8 Intracranial Pressure Monitors
- 5.9 Cerebral Oximeters
- 5.10 Sleep Monitoring Devices
- 5.11 Electromyography Devices
- 5.12 Other Imaging Types
6 Global Brain and Neuroimaging Devices Market, By Procedure
- 6.1 Introduction
- 6.2 Invasive
- 6.3 Non-Invasive
7 Global Brain and Neuroimaging Devices Market, By Application
- 7.1 Introduction
- 7.2 Traumatic Brain Injury
- 7.3 Dementia
- 7.4 Parkinson's Disease
- 7.5 Sleep Disorders
- 7.6 Epilepsy
- 7.7 Huntington's Disease
- 7.8 Headache Disorders
- 7.9 Other Applications
8 Global Brain and Neuroimaging Devices Market, By End User
- 8.1 Introduction
- 8.2 Ambulatory Surgical Centers
- 8.3 Diagnostic Centers
- 8.4 Hospitals
- 8.5 Clinics
9 Global Brain and Neuroimaging Devices Market, By Geography
- 9.1 Introduction
- 9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
- 9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa
10 Key Developments
- 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 10.2 Acquisitions & Mergers
- 10.3 New Product Launch
- 10.4 Expansions
- 10.5 Other Key Strategies
11 Company Profiling
- 11.1 Canon
- 11.2 Hitachi Medical Systems
- 11.3 General Electric Company
- 11.4 Philips
- 11.5 Varian Medical Systems
- 11.6 Siemens
- 11.7 Toshiba Medical Systems
- 11.8 NeuroSoft
- 11.9 Sanrad Medical Systems Pvt. Ltd
- 11.10 Esaote SpA
- 11.11 Medtronic Plc
- 11.12 Elekta AB
- 11.13 Natus Medical Incorporated
- 11.14 Magstim Company Ltd.
- 11.15 Compumedics Limited
- 11.16 Brainlab AG
List of Tables
- Table 1 Global Brain and Neuroimaging Devices Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
- Table 3 Global Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
- Table 4 Global Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
- Table 5 Global Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
- Table 6 Global Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
- Table 7 Global Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
- Table 8 Global Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
- Table 9 Global Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
- Table 10 Global Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
- Table 11 Global Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
- Table 12 Global Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
Table Global Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
- Table 13 Global Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
- Table 14 Global Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
- Table 15 Global Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
- Table 16 Global Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
- Table 17 Global Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
- Table 18 Global Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
- Table 19 Global Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
- Table 20 Global Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
- Table 21 Global Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
- Table 22 Global Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
- Table 23 Global Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
- Table 24 Global Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 25 Global Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
- Table 26 Global Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 27 Global Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
- Table 28 Global Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 29 Global Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
- Table 30 North America Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
- Table 31 North America Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
- Table 32 North America Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
- Table 33 North America Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
- Table 34 North America Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
- Table 35 North America Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
- Table 36 North America Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
- Table 37 North America Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
- Table 38 North America Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
- Table 39 North America Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
- Table 40 North America Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
- Table 41 North America Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
- Table 42 North America Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
- Table 43 North America Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
- Table 44 North America Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
- Table 45 North America Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
- Table 46 North America Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
- Table 47 North America Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
- Table 48 North America Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
- Table 49 North America Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
- Table 50 North America Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
- Table 51 North America Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
- Table 52 North America Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
- Table 53 North America Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
- Table 54 North America Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 55 North America Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
- Table 56 North America Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 57 North America Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
- Table 58 North America Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 59 North America Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
- Table 60 Europe Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
- Table 61 Europe Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
- Table 62 Europe Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
- Table 63 Europe Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
- Table 64 Europe Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
- Table 65 Europe Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
- Table 66 Europe Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
- Table 67 Europe Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
- Table 68 Europe Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
- Table 69 Europe Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
- Table 70 Europe Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
- Table 71 Europe Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
- Table 72 Europe Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
- Table 73 Europe Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
- Table 74 Europe Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
- Table 75 Europe Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
- Table 76 Europe Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
- Table 77 Europe Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
- Table 78 Europe Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
- Table 79 Europe Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
- Table 80 Europe Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
- Table 81 Europe Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
- Table 82 Europe Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
- Table 83 Europe Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
- Table 84 Europe Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 85 Europe Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
- Table 86 Europe Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 87 Europe Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
- Table 88 Europe Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 89 Europe Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
- Table 90 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
- Table 91 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
- Table 92 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
- Table 93 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
- Table 94 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
- Table 95 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
- Table 96 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
- Table 97 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
- Table 98 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
- Table 99 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
- Table 100 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
- Table 101 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
- Table 102 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
- Table 103 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
- Table 104 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
- Table 105 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
- Table 106 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
- Table 107 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
- Table 108 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
- Table 109 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
- Table 110 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
- Table 111 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
- Table 112 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
- Table 113 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
- Table 114 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 115 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
- Table 116 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 117 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
- Table 118 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 119 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
- Table 120 South America Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
- Table 121 South America Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
- Table 122 South America Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
- Table 123 South America Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
- Table 124 South America Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
- Table 125 South America Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
- Table 126 South America Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
- Table 127 South America Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
- Table 128 South America Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
- Table 129 South America Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
- Table 130 South America Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
- Table 131 South America Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
- Table 132 South America Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
- Table 133 South America Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
- Table 134 South America Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
- Table 135 South America Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
- Table 136 South America Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
- Table 137 South America Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
- Table 138 South America Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
- Table 139 South America Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
- Table 140 South America Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
- Table 141 South America Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
- Table 142 South America Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
- Table 143 South America Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
- Table 144 South America Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 145 South America Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
- Table 146 South America Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 147 South America Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
- Table 148 South America Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 149 South America Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
- Table 150 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
- Table 151 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
- Table 152 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
- Table 153 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
- Table 154 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
- Table 155 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
- Table 156 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
- Table 157 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
- Table 158 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
- Table 159 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
- Table 160 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
- Table 161 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
- Table 162 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
- Table 163 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
- Table 164 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
- Table 165 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
- Table 166 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
- Table 167 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
- Table 168 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
- Table 169 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
- Table 170 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
- Table 171 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
- Table 172 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
- Table 173 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
- Table 174 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 175 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
- Table 176 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
- Table 177 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
- Table 178 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 179 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
